Affimed (AFMD)
(Delayed Data from NSDQ)
$4.88 USD
-0.47 (-8.79%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $4.95 +0.07 (1.43%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Income Statements
Fiscal Year end for Affimed NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 44 | 48 | 32 | 24 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 9 | 44 | 48 | 32 | 24 |
Selling & Adminstrative & Depr. & Amort Expenses | 124 | 136 | 124 | 72 | 60 |
Income After Depreciation & Amortization | -115 | -93 | -76 | -40 | -36 |
Non-Operating Income | 1 | 2 | 8 | -8 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -115 | -91 | -68 | -47 | -36 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -115 | -91 | -68 | -47 | -36 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -115 | -91 | -68 | -47 | -36 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -114 | -90 | -74 | -38 | -35 |
Depreciation & Amortization (Cash Flow) | 2 | 3 | 2 | 1 | 1 |
Income After Depreciation & Amortization | -115 | -93 | -76 | -40 | -36 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 14.94 | 14.24 | 11.95 | 8.35 | 6.42 |
Diluted EPS Before Non-Recurring Items | -7.67 | -6.30 | -5.70 | -5.70 | -5.60 |
Diluted Net EPS (GAAP) | -7.67 | -6.37 | -5.68 | -5.71 | -5.60 |
Fiscal Year end for Affimed NV falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.46 | 2.14 | 1.52 | 4.84 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.46 | 2.14 | 1.52 | 4.84 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.90 | 29.26 | 33.62 | 38.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -22.44 | -27.12 | -32.10 | -33.77 |
Non-Operating Income | NA | 0.67 | 0.62 | 0.05 | -0.56 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -21.77 | -26.51 | -32.05 | -34.33 |
Income Taxes | NA | 0.01 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -21.77 | -26.51 | -32.05 | -34.32 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -21.77 | -26.51 | -32.05 | -34.33 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 14.93 | 14.93 | 14.93 |
Diluted EPS Before Non-Recurring Items | NA | NA | -1.70 | -2.20 | -2.30 |
Diluted Net EPS (GAAP) | NA | -1.45 | -1.74 | -2.18 | -2.30 |